Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

The results demonstrated that SCG101 led to sustained clearance of serum hepatitis B surface antigen (HBsAg) and HBV-DNA in heavily pre-treated patients with HBV-related HCC. Notably, 94% of patients ...

The risk of dying from the most common form of primary liver cancer is approximately 30% higher for patients with low ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Researchers have found in a new cohort study that the use of statins in patients with chronic liver disease was associated ...

The risk of dying from the most common form of primary liver cancer is about 30 percent ... were adjusted for factors including underlying liver disease, comorbidities, and specific tumor ...